title: Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design.
abstract: Peptide and protein mimetics are potentially of great value in synthetic vaccine design. The mimetics should function by stimulating the immune system to produce antibodies that recognize the intact parasite. Also the mimetics should be presented to the immune system in a way that leads to efficient antibody production. Here we investigate the application of cyclic peptidomimetics presented on immunopotentiating reconstituted influenza virosomes (IRIVs), a form of antigen delivery that is licensed already for human clinical use, in synthetic vaccine design. We focus on the central (NPNA)(n) repeat region of the circumsporozoite (CS) protein of the malaria parasite Plasmodium falciparum as a model system. Cyclic peptidomimetics of the NPNA repeats were incorporated into both an IRIV and (for comparison) a multiple-antigen peptide (MAP). Both IRIV and MAP delivery forms induced mimetic-specific humoral immune responses in mice, but only with the mimetic-IRIV preparations did a significant fraction of the elicited antibodies cross-react with sporozoites. The results demonstrate that IRIVs are a delivery system suitable for the efficient induction of antibody responses against conformational epitopes by use of cyclic template-bound peptidomimetics. Combined with combinatorial chemistry, this approach may have great potential for the rapid optimization of molecularly defined synthetic vaccine candidates against a wide variety of infectious agents.
authors.affiliation: Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland.
authors.forename: R
authors.initials: R
authors.lastname: Moreno
authors.forename: L
authors.initials: L
authors.lastname: Jiang
authors.forename: K
authors.initials: K
authors.lastname: Moehle
authors.forename: R
authors.initials: R
authors.lastname: Zurbriggen
authors.forename: R
authors.initials: R
authors.lastname: Glück
authors.forename: J A
authors.initials: JA
authors.lastname: Robinson
authors.forename: G
authors.initials: G
authors.lastname: Pluschke
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology; D002626:Chemistry, Pharmaceutical; D016503:Drug Delivery Systems; D015195:Drug Design; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008958:Models, Molecular; D018716:Molecular Mimicry; D010455:Peptides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology*; D011487:Protein Conformation; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000737:chemistry* / Q000276:immunology; D022701:Virosomes / Q000502:physiology
chemical_list: D000911:Antibodies, Monoclonal; D000941:Antigens; D007074:Immunoglobulin G; D010455:Peptides; D014614:Vaccines, Synthetic; D022701:Virosomes